Barrington Research Starts Rosetta Genomics (ROSG) at Outperform w/PT of $7
Tweet Send to a Friend
Barrington Research initiates coverage on Rosetta Genomics (NASDAQ: ROSG) with a Outperform rating and a price target of $7.00.Analyst Charley ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
